<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05006989</url>
  </required_header>
  <id_info>
    <org_study_id>20-1659</org_study_id>
    <nct_id>NCT05006989</nct_id>
  </id_info>
  <brief_title>Blueberry Intake and Infant Gut Health</brief_title>
  <official_title>Blueberry Intake and Infant Gut Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. Highbush Blueberry Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this project is to investigate the effects of blueberries on gut microbiota,&#xD;
      inflammation and innate immunity in breastfed infants during early complementary feeding (~5&#xD;
      to 12 months of age).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Some details are intentionally left to out to preserve the scientific integrity of the study,&#xD;
      and they will be included in the record after the study is completed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gut Microbiome Composition Analyzed using 16S rRNA Amplicon Sequencing</measure>
    <time_frame>Over 7 months</time_frame>
    <description>16S rRNA amplicon sequencing is used to profile taxonomic makeup of fecal specimens. Within the gut microbiome composition, microbial diversity will be summarized using common ecological measures (Good's coverage, Sobs, and Shannon alpha diversity).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infant Growth (Length)</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Measured in cm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infant Growth (Weight)</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Measured in kg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dietary Intake</measure>
    <time_frame>Over 7 months</time_frame>
    <description>3 day dietary recall with results generated by NDSR software</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum hsCRP (High-Sensitivity C-Reactive Protein)</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Measured in mg/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum TNF-α (Tumor Necrosis Factor alpha)</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Measured in pg/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum AGP (Alpha-1-Acid Glycoprotein)</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Measured in mg/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum sCD14 (Soluble CD14)</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Measured in µg/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal Calprotectin</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Measured in µg/g</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blueberry-Specific Food Signatures (Compounds) as Assessed by Metabolomics Analysis</measure>
    <time_frame>Over 7 months</time_frame>
    <description>Metabolomics analysis (nutri-metabolomics) is used to identify and validate food-derived biomarkers that may be classified as biomarkers of intake and/or biomarkers of effect, both of which can be linked to health indicators.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Infant Development</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be provided pre-made whole blueberry freeze-dried powder to be consumed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will be provided placebo powder to be consumed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blueberry Powder</intervention_name>
    <description>Administered 10 grams/day</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Powder</intervention_name>
    <description>Administered 10 grams/day</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Generally healthy&#xD;
&#xD;
          -  Full term (gestational age ≥ 37 weeks)&#xD;
&#xD;
          -  No prior exposure of solid foods&#xD;
&#xD;
          -  Exclusively breastfed (&lt; 2 weeks of cumulative formula exposure)&#xD;
&#xD;
          -  Willing to consume blueberry/placebo powder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having health conditions that would affect normal growth&#xD;
&#xD;
          -  Pre-term&#xD;
&#xD;
          -  Consumed formula for more than two weeks&#xD;
&#xD;
          -  Not willing to consume the blueberry/placebo powders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Months</minimum_age>
    <maximum_age>5 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Minghua Tang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado Denver | Anschutz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Minghua Tang, PhD</last_name>
    <phone>303-724-3248</phone>
    <email>minghua.tang@cuanschutz.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lillian Berman, MS</last_name>
    <phone>303-724-0872</phone>
    <email>lillian.berman@cuanschutz.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Minghua Tang, PhD</last_name>
      <phone>303-724-3248</phone>
      <email>minghua.tang@cuanschutz.edu</email>
    </contact>
    <contact_backup>
      <last_name>Gabrielle Glime</last_name>
      <phone>303-724-1556</phone>
      <email>gabrielle.glime@cuanschutz.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Minghua Tang, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blueberries</keyword>
  <keyword>Gut microbiota</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Innate immunity</keyword>
  <keyword>Early complementary feeding</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

